Pfizer Inc
NYSE: PFE
$28.84
-$0.09 (-0.3%)
Closing Price on October 22, 2024
PFE Articles
ThinkstockWith the markets making new highs seemingly every day, it is understandable that investors may be finding it harder and harder to find stocks that do not appear overvalued, or at a minimum...
Published:
Last Updated:
Jon Ogg24/7 Wall St. wants some insight from readers ahead of earnings season. We have grouped four rival sectors to see which ones investors are more excited about this earnings season. This is a...
Published:
Last Updated:
ThinkstockThe debate over how America’s largest companies use cash will pick up again. Moody’s Investor Services released a study that forecasts how big the cash balances will be at some of...
Published:
Last Updated:
ThinkstockCorporate Cash Piles Up The debate over how America’s largest companies use cash will pick up again. Moody’s Investor Services released a study that forecasts how big the cash balances...
Published:
ThinkstockInvesting in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited pipelines or their very survival depends on a single binary event that...
Published:
Last Updated:
ThinkstockHave some widely owned health care names hit a wall when it comes to growth and earnings? In a research report issued today, Credit Suisse Group Inc. (NYSE: CS) issues some not very...
Published:
Last Updated:
Jon OggThese are some of this Thursday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. AbbVie Inc. (NYSE: ABBV) started as Neutral at Credit Suisse. Akamai...
Published:
ThinkstockCorporate governance issues are sometimes a blessing for shareholders, but they also can crush the rights of shareholders in many cases. Tracking CEO pay of large public companies is now...
Published:
ThinkstockZoetis Inc. (NYSE: ZTS), a spin-off of the animal health business of Pfizer Inc. (NYSE: PFE), held its initial public offering this morning. The company offered 86.1 million shares at $26 a...
Published:
Last Updated:
Jon OggThese are this Wednesday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Amazon.com Inc. (NASDAQ: AMZN) cut to Outperform at CLSA and maintained...
Published:
Last Updated:
U.S. equity markets opened slightly lower this morning following not-much in the way of new data and a wait-and-see attitude until tomorrow’s meeting announcement from the FOMC, which began a...
Published:
Last Updated:
U.S. equity markets opened mixed this morning on relatively little new data. In Europe, Italian consumer confidence rose more than expected and Germany auctioned 12-month bills at a positive yield...
Published:
Last Updated:
Frank Golhen, via Wikimedia CommonsEarnings season is in full swing and the coming week will have many big earnings announcements. 24/7 Wall St. has provided a brief calendar showing current and...
Published:
ThinkstockAfter a strong year of relative performance for pharmaceutical stocks in 2012, the analysts at Jefferies Group Inc. (NYSE: JEF) predict that 2013 could show more of the same. However they...
Published:
Last Updated:
courtesy of Apple Inc.Each January, 24/7 Wall St. forecasts the publicly traded U.S. companies that will have the highest profits in the year ahead. This year, Apple almost certainly will keep first...
Published:
Last Updated: